Company: RGNT
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061821
Chunk: 263

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-07-07
Form: F-1/A
Chunk 263
---
   |
| Balance as of December 31, 2023               |     | $ |  210 |   |

| NOTE 6:- | CONVERTIBLE NOTES |

| a. | During 2020, the Company entered into various Convertible Loan Agreements (the “2020                                                   
 CLAs”). As of December 31, 2024, the Company received $900 from the issuance of convertible notes (the “2020 Notes”)                   
 under the 2020 CLAs. During 2024, the Company received an additional $450 as part of the October 2024 CLA Addendum as described below. |

The 2020 Notes bear no interest and,
unless previously converted (see below), shall become fully due and payable in cash following one (1) year from each 2020 CLA issuance
date. The 2020 Notes may be converted into the most senior securities of the Company or repaid as follows:

| 1. | Automatic conversion upon occurrence of a qualified round – upon the closing of a qualified                                            
 round (transaction or series of related transactions in which shares of the Company having substantially similar rights are issued     
 for an aggregate investment amount of at least $ 3,000), the 2020 Notes shall be automatically be converted into such number of shares 
 of the most senior securities issued in such qualified round, based on a price per share equal to 80% of the lowest price per share    
 actually paid by any investor in the qualified round.                                                                                  |

<div align='center'>F-16</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 6:- | CONVERTIBLE NOTES (Cont.) |

| 2. | Automatic conversion upon occurrence of a merger and acquisition transaction – upon the closing                                     
 of merger and acquisition transaction (as defined in the 2020 CLAs), the 2020 Notes shall be automatically converted into Company’s 
 most senior securities, based on a price per share equal to 80% of the lowest price per attributed to such securities in the merger 
 and acquisition transaction.                                                                                                        |

In October 2021, the Company and 2020
CLA investors reached an agreement according to which, in connection with the raising of the 2021 Notes, the 2020 Notes will be converted
into Ordinary Shares upon the occurrence of an exit event (including an IPO or merger) of the Company based